Class Action Lawsuit Asserts Pure Nootropics Pills to Boost Brain Function Are Unsupported by Science & FDA
According to a new nationwide class action lawsuit, Pure Nootropics, a company that manufactures products that claim to enhance brain function, does not have the approval of science or the United States Food and Drug Administration (FDA).
Robert Gomez and Mark Maurer filed a class action lawsuit against Pure Nootropics, LLC. in a New York federal court on Tuesday, charging violations of New York’s consumer protection laws, unjust enrichment, and breach of warranty.
According to the class action, the defendant claims that the products have a meaningful influence on consumers’ memory, learning, focus, energy, and general mood.
Unfortunately for consumers, the statements and representations made by the defendant regarding the products are incorrect and unsupported by scientific evidence.
Robert Gomez et al., v. Pure Nootropics, LLC
According to the class action, over-the-counter supplements intended to boost memory and focus have grown in popularity in recent years in the United States, with hundreds of thousands of dollars in annual sales. The term “nootropics” refers to supplements that purport to enhance brain function.
Pure Nootropics manufactures and sells several of these “nootropics” under its brand, despite the FDA’s explicit warning that the products are not recognized as safe and effective for the purposes for which they are advertised.
Moreover, the class action asserts that the products are characterized as drugs that require FDA approval prior to their introduction and sale into interstate commerce.
The claim also alleges that Pure Nootropics does not have FDA approval to market the products, and therefore, they are illegal to sell.
Additionally, the Federal Trade Commission reprimanded the company for making product claims that may not be supported by credible scientific evidence, the class action says.
Gomez and Maurer argue that they would not have bought the products or would have paid much less for them if they were aware that they did not have the stated effects on their memory, learning, focus, energy, and mood.
Moreover, Gomez asserts that he relied on the company’s statements that Pure Nootropics Phenylpiracetam improves “mental performance & brain support” and provides a “great boost in mental energy.”
The plaintiffs claim that they are suing on behalf of all customers of Pure Nootropics Aniracetam, Pure Nootropics Oxiracetam, and Pure Nootropics Phenylpiracetam – supplements the company sold with the pretense of enhancing brain function.
According to the class action, there are claims totaling more than $5 million. Gomez and Maurer seek class certification, compensation, interest, restitution, an enjoining order, and attorneys’ fees and costs.
Editor’s Note on Pure Nootropics Class Action Lawsuit 2021 – Fake & Unapproved Brain Boosting Pills:
This is published to inform you of the latest class action lawsuit filed against Pure Nootropics, LLC due to false claims that its products have a meaningful influence on consumers’ memory, learning, focus, energy, and general mood.
Case Name & No.: Robert Gomez et al., v. Pure Nootropics, LLC, Case No. 1:21-cv-03366
Jurisdiction: U.S. District Court; Eastern District of New York
Products/Services: Pure Nootropics Aniracetam, Pure Nootropics Oxiracetam, and Pure Nootropics Phenylpiracetam
Allegations: The company allegedly sold products with the pretense of enhancing brain function
Have you bought Nootropics? Send us a message about your experience by clicking the ‘Contact Us’ button below. We’d be delighted to hear from you.
Suggested Article: Possible CVS Infant Pain Fever Class Action Details 2021.